Literature DB >> 17932041

Stabilization of an immunoglobulin fold domain by an engineered disulfide bond at the buried hydrophobic region.

Yoshihisa Hagihara1, Shouhei Mine, Koichi Uegaki.   

Abstract

We report for the first time the stabilization of an immunoglobulin fold domain by an engineered disulfide bond. In the llama single-domain antibody, which has human chorionic gonadotropin as its specific antigen, Ala49 and Ile70 are buried in the structure. A mutant with an artificial disulfide bond at this position showed a 10 degrees C higher midpoint temperature of thermal unfolding than that without the extra disulfide bond. The modified domains exhibited an antigen binding affinity comparable with that of the wild-type domain. Ala49 and Ile70 are conserved in camel and llama single-domain antibody frameworks. Therefore, domains against different antigens are expected to be stabilized by the engineered disulfide bond examined here. In addition to the effect of the loop constraints in the unfolded state, thermodynamic analysis indicated that internal interaction and hydration also control the stability of domains with disulfide bonds. The change in physical properties resulting from mutation often causes unpredictable and destabilizing effects on these interactions. The introduction of a hydrophobic cystine into the hydrophobic region maintains the hydrophobicity of the protein and is expected to minimize the unfavorable mutational effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17932041     DOI: 10.1074/jbc.M707078200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  The role of intra-domain disulfide bonds in heat-induced irreversible denaturation of camelid single domain VHH antibodies.

Authors:  Yoko Akazawa-Ogawa; Koichi Uegaki; Yoshihisa Hagihara
Journal:  J Biochem       Date:  2015-08-19       Impact factor: 3.387

2.  Evaluation of a noncanonical Cys40-Cys55 disulfide linkage for stabilization of single-domain antibodies.

Authors:  Dae Young Kim; Hiba Kandalaft; Greg Hussack; Shalini Raphael; Wen Ding; John F Kelly; Kevin A Henry; Jamshid Tanha
Journal:  Protein Sci       Date:  2019-03-14       Impact factor: 6.725

3.  Shortened engineered human antibody CH2 domains: increased stability and binding to the human neonatal Fc receptor.

Authors:  Rui Gong; Yanping Wang; Yang Feng; Qi Zhao; Dimiter S Dimitrov
Journal:  J Biol Chem       Date:  2011-06-13       Impact factor: 5.157

4.  Expression, purification, and characterization of engineered antibody CH2 and VH domains.

Authors:  Rui Gong; Weizao Chen; Dimiter S Dimitrov
Journal:  Methods Mol Biol       Date:  2012

5.  Heat-induced irreversible denaturation of the camelid single domain VHH antibody is governed by chemical modifications.

Authors:  Yoko Akazawa-Ogawa; Mizuki Takashima; Young-Ho Lee; Takahisa Ikegami; Yuji Goto; Koichi Uegaki; Yoshihisa Hagihara
Journal:  J Biol Chem       Date:  2014-04-16       Impact factor: 5.157

6.  Structure and development of single domain antibodies as modules for therapeutics and diagnostics.

Authors:  Robert J Hoey; Hyeyoung Eom; James R Horn
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-09

7.  Probing residue-specific interactions in the stabilization of proteins using high-resolution NMR: a study of disulfide bond compensation.

Authors:  Andria L Skinner; Jennifer S Laurence
Journal:  J Pharm Sci       Date:  2010-06       Impact factor: 3.534

Review 8.  Effects of localized interactions and surface properties on stability of protein-based therapeutics.

Authors:  Brittney J Mills; Jennifer S Laurence Chadwick
Journal:  J Pharm Pharmacol       Date:  2016-11-10       Impact factor: 3.765

9.  Engineering antibody fragments to fold in the absence of disulfide bonds.

Authors:  Min Jeong Seo; Ki Jun Jeong; Clinton E Leysath; Andrew D Ellington; Brent L Iverson; George Georgiou
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

10.  Novel vascular endothelial growth factor D variants with increased biological activity.

Authors:  Pyry I Toivanen; Tiina Nieminen; Lenita Viitanen; Annamari Alitalo; Miia Roschier; Suvi Jauhiainen; Johanna E Markkanen; Olli H Laitinen; Tomi T Airenne; Tiina A Salminen; Mark S Johnson; Kari J Airenne; Seppo Ylä-Herttuala
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.